Category: Latest News
-

Capricor Therapeutics Deramiocel PDUFA Date Extended to November as FDA Reviews BLA Amendment
Capricor Therapeutics (NASDAQ:CAPR) faces a three-month extension to the FDA review timeline for Deramiocel after the agency moved the PDUFA target action date for the Duchenne muscular dystrophy cell therapy from August 22 to November 22, 2026. The extension follows Capricor’s submission of a major amendment containing 24-month open-label extension data from the Phase 3…
-

BTC Digital Georgia 10MW Cryptocurrency Computing Project Nears Deployment Readiness
BTC Digital Ltd. (NASDAQ:BTCT) has completed construction of its 10-megawatt cryptocurrency computing infrastructure project in Georgia, with the facility expected to become ready for mining machine deployment and the start of digital asset mining operations within approximately two months. At full deployment, the site is designed to support up to approximately 900,000 TH/s, or 900…
-

Innovative Eyewear Expands Lucyd Armor Into More Than 150 U.S. Retail Stores
Innovative Eyewear, Inc. (NASDAQ:LUCY) is expanding Lucyd Armor into more than 150 stores operated by one of the largest big box retailers in the United States, giving the smart eyewear company a potentially significant new physical retail channel. The test rollout is already underway, with sales expected to begin in October. The retailer was not…
-

Roche Elecsys pTau217 Receives FDA Clearance for Alzheimer’s Disease Assessment
Roche (USOTC:RHHBY) has received FDA clearance for its Elecsys pTau217 blood test, giving clinicians in primary and specialty care a new blood-based tool for assessing amyloid pathology associated with Alzheimer’s disease in people aged 55 and older who have signs, symptoms or complaints of cognitive decline. The clearance is commercially significant because Elecsys pTau217 can…
-

Expion Energy Acquires Louisiana Oil and Gas Assets in Strategic Expansion
Expion Energy, Inc. (NASDAQ:XPON), formerly Expion360 Inc., has acquired oil and gas assets in Eastern Louisiana, marking its first entry into the sector as the company broadens its strategy beyond its established energy storage business. The transaction includes approximately 3,000 net acres of existing leasehold, a wellbore and mineral title research covering roughly 13,000 net…
-

United Therapeutics Ralinepag NDA Accepted by FDA With June 2027 Decision Date
United Therapeutics Corporation (NASDAQ:UTHR) has moved ralinepag into formal FDA review after the regulator accepted its New Drug Application for the investigational pulmonary arterial hypertension treatment. The FDA filing acceptance establishes a Prescription Drug User Fee Act (PDUFA) target action date of June 24, 2027, giving investors a defined regulatory catalyst following positive Phase 3…
-

SU Group Secures Exclusive Macao Rights for Inspec Spider Robotic Inspection Solution
SU Group Holdings Limited (NASDAQ:SUGP) has secured exclusive Macao distribution rights for the Inspec Spider robotic infrastructure inspection system, adding a new potential revenue stream to its recently established operation in the region. The agreement gives subsidiary Shine Union (Macao) Limited sole rights to market, distribute and sell the high-mast inspection technology in Macao, while…
-

Lion Group Holding Reaffirms Long-Term HYPE Holdings With $15.8 Million Position
Lion Group Holding Ltd. (NASDAQ:LGHL) says it remains committed to holding its Hyperliquid (HYPE) tokens, maintaining an approximately 195,000-token position as part of its cryptocurrency treasury management strategy. The company said the HYPE holdings were valued at approximately $15.8 million as of August 24, 2026, based on prevailing market prices, while confirming it has not…
-

U.S. Stocks Set for Cautious Open Ahead of Nvidia Earnings and Jackson Hole: Dow Jones, S&P, Nasdaq, Wall Street Futures
U.S. stock futures pointed to a broadly flat start on Monday, suggesting Wall Street could struggle for direction as investors look ahead to Nvidia’s (NASDAQ:NVDA) quarterly results and the Jackson Hole economic symposium later this week. The muted outlook follows Friday’s rebound, when the major indices recovered some ground after Thursday’s sharp sell-off. Despite those…
-

IBM Unveils Dual-Architecture Mainframe Processor With Native Arm Support
IBM (NYSE:IBM) has unveiled a new dual-architecture mainframe processor designed to support both IBM and Arm computing environments on future IBM Z and LinuxONE systems. Presented at the Hot Chips conference, the processor represents the first major development to emerge from the collaboration between IBM and Arm announced in April 2026. The technology is intended…